Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -25.00% | -17.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.00% | -17.65% | |||
| Cost of Revenue | -16.04% | -23.67% | |||
| Gross Profit | 12.21% | 25.99% | |||
| SG&A Expenses | -7.09% | -0.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.22% | 2.07% | |||
| Operating Income | 9.05% | -2.35% | |||
| Income Before Tax | 22.52% | -51.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.52% | -51.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.52% | -51.00% | |||
| EBIT | 9.05% | -2.35% | |||
| EBITDA | 9.12% | -2.22% | |||
| EPS Basic | -25.65% | -38.08% | |||
| Normalized Basic EPS | 7.00% | -50.83% | |||
| EPS Diluted | -27.18% | -38.08% | |||
| Normalized Diluted EPS | 7.00% | -50.83% | |||
| Average Basic Shares Outstanding | -16.68% | 0.08% | |||
| Average Diluted Shares Outstanding | -16.68% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.57% | -- | |||